UNSPSC 51241711: Polyvinyl alcohol/thimerosal

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241711 Polyvinyl alcohol/thimerosal is a Commodity code under which state and local governments procure pharmaceutical and over-the-counter products through cooperative purchasing vehicles, particularly multi-state alliances. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 seeking manufacturers of generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities in Minnesota and Oregon. Vendors must maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and submit detailed product information including National Drug Codes, SKUs, UPCs, generic descriptions, strength, dosage form, trade names, packaging configurations, and manufacturing locations. All products must be available in the marketplace by May 15, 2026, with awarded contracts effective July 1, 2026.

The MMCAP RFP represents a multi-award cooperative opportunity spanning the Upper Midwest and Pacific Northwest, with evaluation criteria weighted heavily toward price competitiveness (75 percent), followed by fixed pricing (10 percent) and administrative compliance factors including EDI capability, administrative fee agreement, and data format requirements (each 5 percent). Vendors must carry commercial general liability coverage of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million. The contract term runs two years for new responders with optional MMCAP extensions, and incumbent vendors align with existing agreement expiration dates through June 30, 2028. Proposals were due March 26, 2026, with a question cutoff of February 18, 2026. No specific set-aside designations or disadvantaged-business restrictions are disclosed in available documentation, and award values are not disclosed; however, vendors will owe a 3 percent administrative fee on all contract purchases and face performance penalties ranging from $200 to $1,500 per violation.